Connect
MJA
MJA

Prevention of cardiovascular disease: an evidence-based clinical aid 2004

Greg R Fulcher, Greg W Conner and John V Amerena, Practical Implementation Taskforce for the Prevention of Cardiovascular Disease
Med J Aust 2004; 181 (6): . || doi: 10.5694/j.1326-5377.2004.tb06317.x
Published online: 20 September 2004

Cardiovascular disease is the leading cause of morbidity and mortality in Australia. It is therefore important that all medical practitioners are familiar with the well documented risk factors for cardiovascular disease, as well as the outcome benefits of pharmacological and other interventions.

  • Greg R Fulcher1
  • Greg W Conner2
  • John V Amerena3
  • Practical Implementation Taskforce for the Prevention of Cardiovascular Disease

  • 0 Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, St Leonards, NSW.
  • 1 Cardiovascular Diagnostic Services, Liverpool, NSW.
  • 2 Geelong Hospital, and Department of Clinical and Biomedical Sciences, University of Melbourne, Melbourne, VIC.

Correspondence: gfulcher@med.usyd.edu.au

Acknowledgements: 

The taskforce steering committee would like to acknowledge the contributions of the writing committee: Dr Greg R Fulcher, Dr John V Amarena, Dr Greg W Conner, Professor Richard E Gilbert and Professor Graeme J Hankey.

Competing interests:

A summary of the competing interests of the members of the Practical Implementation Task Force is given in Box 2.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.